Effectiveness of Adjunctive High-Dose Infliximab Therapy to Improve Disability-Free Survival Among Patients With Severe Central Nervous System Tuberculosis: A Matched Retrospective Cohort Study. - Manesh A; Gautam P; Kumar D SS; Mannam P; Jasper A; Gunasekaran K; Thomas NC; Benjamin RN; Inbaraj LR; Devasagayam E; George MM; Karthik R; et al. (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023)